SEC Filing Summary: Clover Health Investments, Corp. (CLOV)
Business Context and Reporting Period
This Form 8-K reports on the results of the 2025 Annual Meeting of Stockholders held virtually on June 10, 2025. Clover Health Investments, Corp. is a remote-first company incorporated in Delaware with no physical headquarters. The filing details the voting outcomes for three proposals presented to stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting results rather than financial performance.
Material Changes and Voting Results
Stockholders voted on three proposals with the following certified results:
- Proposal 1 (Election of Directors): Dr. Anna U. Loengard and William G. Robinson, Jr. were elected as Class I Directors to serve until 2028.
- Dr. Anna U. Loengard: 976,901,062 votes FOR; 20,121,520 votes WITHHELD.
- William G. Robinson, Jr.: 969,995,918 votes FOR; 27,026,664 votes WITHHELD.
- Proposal 2 (Executive Compensation): Stockholders approved the non-binding advisory vote on Named Executive Officer compensation for 2024.
- Results: 988,724,280 votes FOR; 6,196,982 votes AGAINST; 2,101,320 votes ABSTAIN.
- Proposal 3 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Results: 1,154,406,035 votes FOR; 3,060,080 votes AGAINST; 1,549,510 votes ABSTAIN.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural reporting of the annual meeting outcomes.
Key Facts for Investor Verification
- Verify the definitive proxy statement filed on April 28, 2025, for detailed biographies of the newly elected directors and executive compensation specifics.
- Confirm the dual-class voting structure where Class B shares carry ten votes per share compared to one vote per Class A share.
- Note the significant number of broker non-votes (161,993,043) recorded for the director elections and executive compensation vote.
- Review the upcoming fiscal year 2025 financial reports to assess the company's financial health, as this 8-K contains no financial data.